Zobrazeno 91 - 100
of 17 952
pro vyhledávání: ''
Publikováno v:
Cancer Medicine, Vol 10, Iss 16, Pp 5545-5556 (2021)
Cancer Medicine
Cancer Medicine
Epigenetic regulation is important for cancer tumor metastasis and progression, including lung and liver cancer. However, the mechanism of epigenetic regulation in liver cancer leaves much to be discussed. According to a previous study, p300/CBP‐as
Autor:
Yongqiang Zheng, Haotian Ma, Pengcheng Yang, Ying Chen, Yun Yang, Kaixu Yu, Jiayuan Chen, Bian Wu
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Cancer
BMC Cancer
Background Receiving a cancer diagnosis may trigger immediate fatal non-cancer health outcomes in addition to dying of cancer itself. We aim to investigate the full pattern of non-cancer deaths in patients within a year of a cancer diagnosis. Methods
Autor:
Yuxuan Xiao, Qiran Zhang, Yalun Li, Chengdi Wang, Hanlin Gong, Jingwei Li, Jiayang Wu, Lujia Song
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-18 (2021)
BMC Cancer
BMC Cancer
Background The advent of immune checkpoint inhibitors (ICIs) therapy has resulted in significant survival benefits in patients with non-small-cell lung cancer (NSCLC) without increasing toxicity. However, the utilisation of immunotherapy for small-ce
Autor:
Qianxue Wu, Hongyuan Li, Qing Li, Wenming Zhu, Zhuyue Li, Xiang Zhang, Kang Wang, Ling Yang, Yang Shi
Publikováno v:
Clinical Breast Cancer. 21:360-372
Purpose: Although patients diagnosed with ductal carcinoma in situ (DCIS) harbor excellent overall survival after breast conserving therapy, the evidence regarding to surgical management for ipsilateral breast tumor recurrence (IBTR) is scarce. This
Autor:
Abdurrahman Aldiab, Ammar C. Al-Rikabi, Khalid Alsaleh, Nashwa Abd El-Aziz, Tareq Salah, Sufia Husain, Maria Arafah
Publikováno v:
Clinical Breast Cancer. 21:e362-e367
Progesterone receptor (PR), estrogen receptor (ER), and human epidermal growth factor receptor 2 (HER2) significantly influence disease prognosis and therapeutic response in patients with breast cancer. Neoadjuvant chemotherapy (NACT) can change the
Autor:
Songhua Yuan, Shuiling Zu, Fuqiang Wang, Haijun Yang, Ying Yi, Jianping Liu, Xia Chen, Fangjie He
Publikováno v:
Cancer Medicine, Vol 10, Iss 16, Pp 5429-5436 (2021)
Cancer Medicine
Cancer Medicine
Objective This study aimed to identify patients with stage IB1‐IIA2 cervical cancer at low risk for lymph node metastasis (LNM) using preoperative magnetic resonance imaging (MRI) parameters. Methods Clinical and MRI data of patients with stage IB1
Publikováno v:
Clinical Breast Cancer. 21:e471-e478
Male breast cancer (MBC) comprises1% of all cancers and continues to rise. Because of rarity, there is paucity in the literature; therefore, management of MBC is generalized from female breast cancer (FBC).Data from 152 VA Medical Centers were used t
Autor:
Iris Benz-Rüd, Frederik Roos, Marc-Oliver Grimm, Peter J. Goebell, Michael Stöckle, Norbert Marschner, Viktor Grünwald, Marinela Augustin, Michael Staehler, Dunja Klein, Daniel C. Christoph, Fabian Brüning, Karin Potthoff, Johanna Harde, Arnulf Stenzl
MARC‐2, a prospective, multicenter phase IV trial, aimed to investigate clinical outcomes in patients with metastatic renal cell carcinoma (mRCC) treated with everolimus after failure of one initial vascular endothelial growth factor receptor tyros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba42bc5ba1f043adf1d6d505753c4fbd
Publikováno v:
Anticancer research. 42(11)
Very elderly patients may benefit from individualized treatment. A survival score was created for patients aged 80+ receiving radiosurgery or fractionated stereotactic radiotherapy for 1-2 brain metastases.Thirteen patients were retrospectively evalu
Changes in survival over time for primary brain and other CNS tumors in the United States, 2004-2017
Autor:
Gino Cioffi, Kristin A. Waite, Jacob L. Edelson, Carol Kruchko, Quinn T. Ostrom, Jill S. Barnholtz-Sloan
Publikováno v:
Journal of neuro-oncology. 160(1)
Purpose Despite advances in cancer diagnosis and clinical care, survival for many primary brain and other central nervous system (CNS) tumors remain poor. This study performs a comprehensive survival analysis on these tumors. Methods Survival differe